TOTH A ERNEST JR
SEC CIK 1280273 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | SVP, CFO | 283.5K | — | $242.9K | 8 | 2023-03-09 | 2026-05-05 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 17:33 | 2026-05-05 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | CFO | F - Tax | $4.18 | -92.7K | 283.5K | -25% | -$387.3K | |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | CFO | S - Sale | $4.17 | -58.3K | 376.1K | -13% | -$242.9K |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | CFO | A - Grant | $0.00 | +95.0K | 434.4K | +28% | $0 |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | CFO | A - Grant | $0.00 | +110.0K | 358.3K | +44% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | CFO | F - Tax | $2.65 | -18.9K | 348.1K | -5% | -$50.2K |
| 2024-03-12 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | SVP, CFO | F - Tax | $4.88 | -11.7K | 248.3K | -5% | -$57.1K | |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | SVP, CFO | A - Grant | $0.00 | +120.0K | 260.0K | +86% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | TOTH A ERNEST JR | SVP, CFO | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations